• Profile
Close

Efficacy of methotrexate as add on therapy to H1 antihistamine in difficult to treat chronic urticaria: A systematic review and meta‐analysis of randomized clinical trials

Dermatologic Therapy Jul 30, 2020

Patil AD, et al. - In this systematic review and meta‐analysis of randomized clinical trials (RCTs), researchers sought to assess the effectiveness of methotrexate as add on therapy to H1 antihistamine in difficult to treat chronic urticaria. PubMed” and “Google Scholar” have been systematically searched to identify randomized clinical trials with methotrexate in patients with chronic urticaria who do not react to second-generation antihistamines. Two RCTs (n = 104) have been involved. According to findings, adding methotrexate to antihistamine in the treatment of difficult to treat urticaria did not have a major effect. The drawback of this meta-analysis is the use of only two randomized controlled trials.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay